-
PDF
- Split View
-
Views
-
Cite
Cite
Madelon van Wely, Irene Kwan, Anna L. Burt, Jane Thomas, Andy Vail, Fulco Van der Veen, Hesham G. Al-Inany, Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review, Human Reproduction Update, Volume 18, Issue 3, May/June 2012, Page 340, https://doi.org/10.1093/humupd/dms012
- Share Icon Share
Human Reproduction Update 2012;18:111
The authors regret an error in the originally published In A Nutshell article.
In the originally published version of the figure there were two errors. The first error concerned the second gonadotrophin group – this should be FSH-P instead of FSH-HP. The second error was the number of live births given in the FSH-P subgroup in the recombinant FSH column – this should be 171/825 instead of 171/1367.
The correct version of the figure is reproduced below.1
